Submission of Matters to a Vote of Security Holders

SEC Filing Summary: Ekso Bionics Holdings, Inc. (8-K)

Business Context and Reporting Period

This Form 8-K Current Report, dated June 10, 2021, details the results of the 2021 Annual Meeting of Stockholders for Ekso Bionics Holdings, Inc. The registrant is incorporated in Nevada and trades on the Nasdaq Capital Market under the symbol EKSO. The filing covers events occurring on June 10, 2021.

Key Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting outcomes rather than financial performance.

Material Changes and Voting Results

A quorum was established with 6,830,302 shares present out of 12,654,994 shares outstanding. Stockholders approved three key proposals:

  • Proposal 1 (Director Election): All six nominees were elected. Broker non-votes totaled 2,875,178 for each director. Votes withheld ranged from 471,614 to 864,253 depending on the nominee.
  • Proposal 2 (Executive Compensation): The advisory vote on named executive officer compensation was approved with 3,350,121 votes for, 167,099 against, and 437,904 abstentions.
  • Proposal 3 (Auditor Ratification): The appointment of OUM & Co., LLP as independent auditors for the year ending December 31, 2021, was ratified with 6,221,884 votes for, 147,873 against, and 460,545 abstentions.

Guidance, Outlook, and Risks

The filing text does not provide a clear value for future guidance, management outlook, specific risks, contingencies, or unusual items. The document is limited to the reporting of the annual meeting vote tallies.

Investor Verification Checklist

  • Verify the final composition of the Board of Directors following the election of the six approved nominees.
  • Confirm the engagement of OUM & Co., LLP as the independent auditor for the fiscal year ending December 31, 2021.
  • Review the Proxy Statement dated April 29, 2021, for detailed executive compensation data referenced in Proposal 2.
  • Monitor subsequent filings for the company's financial results, as this 8-K contains no financial metrics.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.